doxepin has been researched along with Cockayne-Touraine Disease in 2 studies
Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wakelin, SH | 1 |
| Rycroft, RJ | 1 |
| Horn, HM | 1 |
| Tidman, MJ | 1 |
| Aldridge, RD | 1 |
2 other studies available for doxepin and Cockayne-Touraine Disease
| Article | Year |
|---|---|
Allergic contact dermatitis from doxepin.
Topics: Adult; Antipruritics; Dermatitis, Allergic Contact; Doxepin; Epidermolysis Bullosa Dystrophica; Huma | 1999 |
Allergic contact dermatitis due to doxepin cream in a patient with dystrophic epidermolysis bullosa.
Topics: Administration, Cutaneous; Antipruritics; Dermatitis, Allergic Contact; Diagnosis, Differential; Dox | 2001 |